Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 10.32
-0.09 (-0.86%)
Dec 31, 2025, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 527.25 million as of December 31, 2025. Its market cap has increased by 213.58% in one year.
Market Cap
527.25M
Enterprise Value
445.53M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.32
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 527.25M, an increase of 575.90%. That is a compound annual growth rate of 48.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 527.25M | 228.18% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | 78.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.72B |
| Green Thumb Industries | 2.50B |
| dentalcorp Holdings | 2.18B |
| Extendicare | 2.01B |
| Sienna Senior Living | 1.96B |
| Trulieve Cannabis | 1.77B |
| Cronos Group | 1.39B |
| WELL Health Technologies | 995.41M |